首页> 外国专利> Tafamidis and its pharmaceutically acceptable salts, including tafamidis meglumine salt (VYNDAQEL®)

Tafamidis and its pharmaceutically acceptable salts, including tafamidis meglumine salt (VYNDAQEL®)

机译:他法米地及其药学上可接受的盐,包括他法米地葡甲胺盐(VYNDAQEL®)

摘要

Kinetic stabilization of the native state of transthyretin is an effective mechanism for preventing protein misfolding. Because transthyretin misfolding plays an important role in transthyretin amyloid diseases, inhibiting such misfolding can be used as an effective treatment or prophylaxis for such diseases. Treatment methods, screening methods, as well as specific transthyretin stabilizing compounds are disclosed.
机译:运甲状腺素蛋白天然状态的动力学稳定是防止蛋白质错误折叠的有效机制。因为运甲状腺素蛋白错误折叠在运甲状腺素蛋白淀粉样蛋白疾病中起重要作用,所以抑制这种错误折叠可以用作此类疾病的有效治疗或预防。公开了治疗方法,筛选方法以及特定的运甲状腺素蛋白稳定化合物。

著录项

  • 公开/公告号LU91935I2

    专利类型

  • 公开/公告日2012-03-26

    原文格式PDF

  • 申请/专利权人 THE SCRIPPS RESEARCH INSTITUTE;

    申请/专利号LU20120091935C

  • 发明设计人

    申请日2012-01-25

  • 分类号A61K;A61K31/03;A61K31/055;A61K31/192;C07D263/56;C07D263/57;C07K1;G01N33/50;G01N33/53;G01N33/567;G01N33/68;

  • 国家 LU

  • 入库时间 2022-08-21 17:23:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号